We funded Unravel Biosciences with 38000 to generate primary RNA sequencing data to virtually screen over 40000 FDA approved and GRAS generally recognized as safe compounds The funded study aims to identify potential treatments mitigate adverse effets and accelerate the path to clinical trialsultimately expanding therapuetic possibilities for individuals with SETBP1-HD and SETBP1-RD Following this study identified therapeutics will be further evaluated in validated SETBP1 research models The University of Texas Southwestern Medical Center was funded 6250 to enable deeper understanding of how SETBP1 alters brain development cell identity and behavior via a preclinical mouse model of SETBP1 The University of Alabama at Birmingham was funded 6250 to identify drug repurposing candidates for SETBP1 using advanced computational approaches and publically avialable SETBP1-HD gene expression data The result of this study will be to provide another set of independently derived drug cancdidates for SETBP1-HD from already approved FDA drugs Hospital for Sick Children in Toronto Ontario Canada was funded 5643 USD to establish human neurons and brain organoid models of SETBP1 to reveal how the loss of gene impairs human neural cells and whether the symptoms are reversible Success of this trial could provide a foundation for future discoveries and advance the devlopment of future treatments
Main program · fiscal year 2025
The program services of the Society are limited to funding research in a specific rare genetic condition See explanations above from Part I line 10 for details on research that was funded The researched condition is largely unknown and as such all discoveries open avenues for further research As mentioned above 5643 USD was wire transfered to a research hospital in Canada
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$121,528Fiscal year 2025
Expenses$59,472Fiscal year 2025
Total assets—Fiscal year 2025
Total liabilities—Fiscal year 2025
Fiscal year ending December2025
Revenue$121,528
Expenses$59,472
Net income$62,056
Net assets$230,378
Notable sources of revenue
Percent of total revenue
Contributions
$117,114
96.4%
Program services
$385
0.3%
Investment income
$4,029
3.3%
Other (net)
$0
0.0%
Assets / debt
Total assets
—
Total liabilities
—
Net assets
$230,378
Compensation
Not in our extract for this year.
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?